Park Ha Biological Technology Co., Ltd.
BYAH Nasdaq
SEC CIK 1986247
Follow Park Ha Biological Technology Co., Ltd.
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY25 | $2.5M | −$24.4M |
| FY24 | $2.4M | $478.6K |
| FY23 | $2.5M | $852K |
| FY22 | $1.9M | $191.3K |
| FY21 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY25 | 94.4% | −956.5% | −965% |
| FY24 | 91.8% | 33.3% | 20.1% |
| FY23 | 87.4% | 48% | 34.6% |
| FY22 | 73.5% | 10.3% | 10% |
| FY21 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY25 | −$3K |
| FY24 | $874.9K |
| FY23 | $103.9K |
| FY22 | $1.4M |
| FY21 | - |
- Park Ha Biological Technology Co., Ltd.
- Materials median
Show the numbers
| Year | Park Ha Biological Technology Co., Ltd. | Materials median |
|---|---|---|
| FY25 | −965% | 2.3% |
| FY24 | 20.1% | 3.4% |
| FY23 | 34.6% | 4.4% |
| FY22 | 10% | 5.6% |
| FY21 | - | 6.4% |